Research and Markets: Global Dengue Fever Pipeline Report 2014-2017
Research and Markets (http://www.researchandmarkets.com/research/qzfbph/dengue_fever) has announced the addition of the "Dengue Fever Pipeline Highlights - 2014 Update" report to their offering.
The latest report Dengue Fever Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Dengue Fever market. It covers emerging therapies for Dengue Fever in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
- The report provides Dengue Fever pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
- The report provides Dengue Fever pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
- The report provides Dengue Fever pipeline molecules by the Originator Company.
Short-term Launch Highlights:
- Find out which Dengue Fever pipeline products will be launched in the US and Ex-US till 2017.
- Dengue Fever phase 3 clinical trial pipeline molecules
- Dengue Fever phase 2 clinical trial pipeline molecules
- Dengue Fever phase 1 clinical trial pipeline molecules
- Dengue Fever preclinical research pipeline molecules
- Dengue Fever discovery stage pipeline molecules
- Dengue Fever pipeline molecules short-term launch highlights
For more information visit http://www.researchandmarkets.com/research/qzfbph/dengue_fever